Sanyuan Bio plans to use its own funds to increase capital in Shenzhen Youwei Optoelectronics Technology Co., Ltd. by 30 million yuan. After the transaction, it will hold a 10.7143% stake in Youwei Optoelectronics. Youwei Optoelectronics was established in July 2023 and is a research and development startup. It is engaged in CLBO crystals and their all-solid-state lasers, and has developed a technical route for growing YIG bulk single crystals using the optical floating zone method. However, it has not yet achieved profitability. Its 2025 operating revenue was 11.3588 million yuan, with a net loss of 7.5395 million yuan. Sanyuan Bio stated that this investment is aimed at cultivating a medium- to long-term second growth curve for the company while maintaining its core business in healthy sweetening ingredients. The investment amount accounts for 0.68% of the company's latest audited total assets, making it a prudent investment attempt with controllable risks. The announcement also cautioned that the target company may face multiple risks, including failure in technology research and development, industrialization falling short of expectations, loss of core personnel, and investment impairment.
Shandong Sanyuan Biotechnology Co.Ltd.Sanyuan Bio plans a 30 million yuan capital increase in Youwei Optoelectronics, a risky startup with losses, to cultivate a second growth curve; investment is small (0.68% of assets) but carries risks.